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Background: Relative to other aspects of Down syndrome, remarkably little is known about the psychiatric
problems experienced by youth and young adults with this syndrome and if these problems differ from others with
intellectual disabilities. Yet adolescence and young adulthood are particularly vulnerable time periods, as they
involve multiple life transitions in educational, medical, and other service systems.
Methods: This study compared the psychiatric diagnoses of 49 adolescent and young adult patients with Down
syndrome to 70 patients with other intellectual disabilities (IDs). The groups were similar in age, gender, and level
of intellectual impairment. The 119 participants, aged 13 to 29 years (M = 21) were evaluated in one of two
specialized psychiatric clinics.
Results: In contrast to previous literature, those with Down syndrome versus other IDs had significantly higher rates
of psychosis NOS or depression with psychotic features (43% versus 13%). Unlike the ID group, psychosis was
predominantly seen in females with Down syndrome. Marked motoric slowing in performing routine daily activities
or in expressive language was manifested in 17% of patients with Down syndrome. No group differences were
found in anxiety or depressive disorders, and the ID group had significantly higher rates of bipolar and impulse
control disorders.
Conclusions: These preliminary observations warrant further studies on genetic, neurological, and psychosocial
factors that place some young people with Down syndrome or other IDs at high risk for severe psychiatric illness.
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A growing literature describes the behavioral phenotypes
of people with neurodevelopmental disorders, but not all
neurodevelopmental disorders receive equal research
attention. Down syndrome, for example, is understudied
both in relation to rare, clinically severe disorders and to
more prevalent conditions such as autism spectrum
disorders, or attention deficit hyperactivity disorder [1].
Not surprisingly then, research gaps are increasingly
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unless otherwise stated.One salient research gap concerns co-occurring men-
tal health disorders in Down syndrome and how these
are manifested in different age groups [2]. Older adults
with Down syndrome, for example, are relatively well
studied because of their increased risks of Alzheimer’s
disease, attributed to the third copy and overexpression
of the amyloid precursor protein gene on chromosome
21 (for a review, see Zigman [4]). Depressive symptoms
in this older age group have also been described, and
careful evaluations are necessary to differentiate a
depressive disorder from the early clinical signs of
dementia [5]. On the other end of the developmental
spectrum, young children with Down syndrome appear
to have lower overall rates of disruptive behaviors as well
as distinctive social, motivational, and attention profiles
[6-8]. In contrast to older adults or children, remarkably. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Dykens et al. Journal of Neurodevelopmental Disorders  (2015) 7:9 Page 2 of 8little is known about the behavioral or emotional disorders
of adolescents or young adults with Down syndrome [2,3].
This research gap is an important one to fill as young
adults with intellectual disabilities, including Down syn-
drome, are transitioning out of educational settings and
entering adult service systems that are often more frag-
mented and less readily available [9]. These young adults
also leave pediatric care, and problems transitioning to
adult medicine are associated with persistent health care
disparities in the intellectual disability population [10].
People with intellectual disability (ID) and psychiatric
problems may be more sensitive or negatively impacted
by life events [11], further justifying the need for studies
in the adolescent to young adult transitional period.
This study identified psychiatric diagnoses in 13- to
29-year-old adolescent and young adult patients with
Down syndrome and other intellectual disabilities, but
with an eye toward also addressing two inconsistencies
in the Down syndrome literature. First, consistent with
higher risks of psychopathology in the ID versus general
population, early studies found that adults with Down
syndrome were especially prone to depressive or anxiety
disorders [12-15]. In contrast, recent reports suggest that
while some adolescents or young adults may become
more withdrawn or quiet over time [16,17], rates of de-
pressive disorders are no higher in Down syndrome than
others with intellectual disabilities [18].
A second and related research discrepancy relates to
the severity of problems as reflected in community ver-
sus clinic samples. Relative to others with intellectual
disabilities, much lower rates of behavior or emotional
problems are consistently found in non-referred, com-
munity samples of individuals with Down syndrome
[5,18,19]. Such studies find that impulsivity, aggressive,
and disruptive behaviors are particularly low in Down
syndrome and lessen over time [16,19,20].
Studies of clinic or hospitalized patients with Down syn-
drome paint a different picture involving more severe or
unusual psychiatric concerns. Prasher [21], for example,
identified ‘young adult disintegrative syndrome’ character-
ized by depression, withdrawal, and significant regression
in cognitive, language, or motor functioning in an unspeci-
fied number of young patients with Down syndrome.
Similarly, Devenny and Mathews [22] conducted a medical
chart review of 197 patients with Down syndrome and
identified 14 adolescents with regressions in cognitive and
adaptive skills, as well as with depression, aggression,
compulsivity, and withdrawal. Finally, Charlot et al. [23]
identified what they called ‘obsessional slowness’ in
performing routine daily living skills in 11 young adult pa-
tients with Down syndrome. Motoric freezing and tics
were also observed in these patients, who did not appear
to lose skills but to perform them at a markedly slower
pace, features strongly suggestive of catatonia.These clinic observations warrant further study as they
fall outside the scope of the usual Down syndrome pheno-
type and may provide new insights into the range of
phenotypic expression in this syndrome. This preliminary
study compares the types and correlates of psychiatric dis-
orders in adolescent and young adult clinic patients with
Down syndrome versus intellectual disabilities.
Methods
Participants
This study enrolled 119 adolescent or young adult pa-
tients with intellectual disabilities (65 males, 54 females)
aged 13 to 29 years (M = 21.73 years; SD = 4.27) who
were seen in one of two specialized psychiatric clinics.
Of these, 49 had documented etiologies of Down syn-
drome, and 70 had other IDs. Most members of the ID
group, 78%, had unknown or undocumented causes,
while 15% had histories of birth trauma, prenatal expo-
sures, and neural injuries, and 7% had genetic syn-
dromes (one case each of Lowe, Smith-Magenis, fragile
X, 22q deletion, and Cornelia de Lange syndromes).
Because co-occurring autism spectrum disorder (ASD)
is only seen in 5% to 6% of individuals with Down syn-
drome [24,25], patients with primary diagnoses of ASD
were not included in the other intellectual disability
group. This exclusion ensured that the ID comparison
group was similar to the majority of those with Down syn-
drome. Three additional patients with Down syndrome
and ASD were also excluded from the study, resulting in
49 patients with Down syndrome and 70 with ID who did
not have ASD.
IQ test scores were variably obtained through a brief
IQ screener, the Kaufman Brief Intelligence Test-2
(KBIT-2) [26], administered during the initial clinic visit
for 35 patients, or a review of patient’s records that
included previous IQ scores. Given the variability in the
type and timing of IQ tests, broader IQ levels were used
in data analyses (see Table 1).
As shown in Table 1, the Down syndrome versus other
ID groups did not differ in age, gender, or level of intel-
lectual impairment. The Down syndrome group had
equal numbers of males and females, while males were
slightly but not significantly overrepresented in the ID
group. The sample was predominantly Caucasian,
although significant differences were seen in the distri-
bution of African American and Hispanic patients across




Participants and their families were seen in one of two
University-based, outpatient psychiatric clinics on the West
coast (n = 40) or Mid-South (n = 82). Both interdisciplinary
Table 1 Characteristics of patients with Down syndrome





Mean age, years 21.39 (5.40) 22.07 (3.59) t (123) = −.78
13 to 19 years 38% 35% NS
20 to 29 years 62% 65%
Gender 49% M, 51% F 58% M, 42% F NS




Race X2 (3) = 8.65**
Caucasian 69% 71%
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needs of persons with ID, including Down syndrome. Indi-
viduals who were inappropriate clinic referrals and/or did
not merit a psychiatric evaluation were not included in the
study. Although both clinics served a wide age range, this
study only included youth and young adults. Participants
at the two clinic sites did not differ in age, gender, etiology,
or psychiatric diagnoses, and as such, clinic location was
not taken into account in data analyses.Consent
Each clinic adhered to their respective university IRB
procedures, which complied with the Helsinki Declar-
ation. Parents or guardians provided written, informed
consent for specific de-identified information derived
from their clinic intake visits to be used for research
purposes, and they were assured that their participation
in the study was not related to ongoing clinical care.
Consents and data were obtained as patients were seen
over an approximate 2-year period.Clinic team members
Patients were evaluated at each site by an interdisciplinary
team consisting of child psychiatrists, clinical psychologists,
applied behavior analysts, nurses or nurse practitioners,
and social workers. Trainees in each of these disciplines
rotated through the clinics at various times. All senior team
members had undergone disability-specific training within
their respective disciplines and were established mental
health clinicians and supervisors in the field of develop-
mental disabilities.Psychiatric evaluations
All participants received a psychiatric evaluation that
included: an interview with the patient (rapport-building,
modified mental status exam, observations, and interac-
tions); interview with parents and/or care providers
(chief complaint, developmental, educational, psychiatric
and medical histories, present illness, review of systems);
and a review of collateral information derived from
patients’ medical records and as needed from teachers,
other physicians, or vocational/residential staff. Diagnoses
using DSM-IV-TR [27] criteria were made by attending
professionals and agreed upon by the clinical team. The
few disagreements in diagnoses were discussed among
team members at case conferences until consensus was
achieved.
Chart review
Trainees in clinical psychology reviewed the participant’s
records in order to informally verify symptoms associ-
ated with psychiatric diagnoses. This approach was used
as the clinics did not administer symptom checklists.
The trainees also noted if marked motoric slowing was
present in speaking or performing everyday routines.
Results
Types and frequencies of psychiatric diagnoses
Table 2 presents the DSM-IV-TR diagnoses for adolescents
and young adults in each group. As some diagnoses were
relatively infrequent, diagnoses were classified into broader
categories in order to conduct meaningful statistical ana-
lyses. When pertinent, however, Table 2 also notes specific
diagnoses subsumed under these broader categories.
Chi-square analyses (2 × 2; group by yes/no psychiatric
disorder) were conducted to compare diagnostic categories
across groups. As shown in Table 2, those with Down syn-
drome versus other intellectual disabilities had significantly
higher rates of psychosis NOS (35% versus 13%), with an
additional 8% of those with Down syndrome having
depression with psychotic features.
The following is a brief case vignette that exemplifies
concerns seen in patients with Down syndrome, consider-
ing the relatively high rate of psychosis in this group. Psych-
osis was characterized in all cases by apparent auditory or
visual hallucinations and/or delusions, withdrawal, and
diminished communication. Other salient and more vari-
able symptoms included restlessness, agitation, irritability,
and impaired adaptive skills.
A case vignette exemplifying psychosis NOS in Down
syndrome
J.M., a 22 year-old female with Down syndrome and
mild intellectual disabilities (IQ = 58), was a recent high
school graduate who had been a well-liked student. She
lived with her mother, enjoyed caring for her dog and
Table 2 Number and percentages of primary psychiatric diagnoses in Down syndrome versus other ID groups
Down syndrome (N = 49) Intellectual disabilities (N = 70)
N % N % X2 (1), p
Psychosis NOS 17 35% 9 13% 6.46**
Depression with psychosis 4 8% 0 5.33*
Depressive disorders 7 15% 7 10% .12
Bipolar disorder 2 4% 20 29% 14.34***
Anxiety disordersa 9 18% 7 10% .20
Impulse control disorderb 10 20% 27 38% 4.59*
*p < .05; **p < .01, ***p < .001.
aAnxiety disorders included obsessive-compulsive disorder (DS = 4; ID = 2) with remaining diagnoses reflecting generalized anxiety disorder and one case of
separation anxiety.
bImpulse control disorder included five participants with both ADHD and impulse control disorders (DS = 2, ID = 3). Depressive disorders consisted of major
depressive episodes, with one case of dysthymic disorder in the ID group.
Figure 1 Gender differences in psychosis (psychosis NOS plus
depression with psychotic features) in Down syndrome versus
ID groups. The X-axis indicates groups by gender and the Y-axis the
percentage of patients with psychosis-NOS diagnoses.
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most aspects of personal grooming and daily living.
After her graduation, she attended a series of job skills
workshops, but she was not employed and was on a wait
list to be evaluated for employment eligibility. After mul-
tiple months at home, her mother observed J. becoming
increasingly irritable and withdrawn, culminating in a
period of 4 days where she refused to change her clothes
and slept with her light on. J. began talking to herself
and ‘hearing voices inside my head’ and from inside the
toaster. Her grooming deteriorated markedly, her sleep
was disturbed, she became restless and agitated, and had
prolonged conversations with imaginary others, includ-
ing showing them her belongings. She reverted to sleep-
ing with her mother and keeping all the lights on at
night because she was afraid the voices would harm her.
J. was hospitalized and responded well to antipsychotic
medication, yet she was fearful that the voices would
return. Her mother altered her work schedule to be
more available during the day and hired her niece to be
with J. in her absence. Her mother arranged for J. and
her niece to volunteer a few hours a week at an animal
shelter, though J. was not motivated to do so.
Compared to those with Down syndrome, the ID group
had higher rates of bipolar (4% versus 29%) and impulse
control disorders (20% versus 38%). Based on the chart
review, both disorders were characterized by aggressive
and destructive behavior, irritability, and angry outbursts.
Those with bipolar disorder, however, also had depressed
mood and bouts of restlessness, impatience, rapid speech,
and making unrealistic demands.
The Down syndrome and ID groups had similar rates of
depressive (15% versus 10%) and anxiety (18% versus 10%)
disorders. Depression was characterized by sadness, with-
drawal, irritability, lack of interest or disengagement in
usual activities, and impaired adaptive skills. Those with
anxiety disorders manifested excessive generalized worries
or specific fears, and approximately 50% had repetitive,
compulsive-like behaviors.Demographic correlates: age, race, IQ level, gender
To facilitate analyses of possible age effects, the sample
was divided into two age groups: 45 adolescents aged 13
to 19 (M age = 17.22 years, SD = 2.13) and 77 young adults
aged 20 to 30 (M = 24.47 years, SD = 3.23). Chi-square
analyses (age group × psychiatric disorder) conducted
within each group revealed that compared to adolescents,
young adults with Down syndrome were less likely to have
an impulse control disorder (35% versus 10%, respectively,
X2 (1) = 5.20, p < .05). No other significant age effects were
found.
No significant associations were found between level of
intellectual impairment or race/ethnicity for any psychi-
atric diagnosis in either the Down syndrome or ID groups.
However, two gender effects emerged in the Down syn-
drome group. As shown in Figure 1, a full 81% of Down
syndrome patients with psychotic symptoms were females;
X2 (1) = 13.50, p < .001. In contrast, no significant gender
differences in psychosis were seen in those with other IDs,
X2 (1) = .005. Second, the majority (90%) of those with
Down syndrome and impulse control disorder were males,
X2 (1) = 7.92, p < .01, and although males comprised 65%
of impulse control diagnoses in the other ID group, this
was not significant, X2 (1) = .02.
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Extreme slowing was seen in 17% of the Down syndrome
group. These nine patients (four males, five females) had
diagnoses of psychosis (n = 3), depressive (n = 4), or anx-
iety disorders (n = 2). They displayed excessive slowing in
completing everyday routines (for example, taking hours
to get dressed or eat) and long latencies (for example, 10
to 20 min) in responding to simple, previously mastered
questions, even with repeated prompts.
Discussion
This preliminary, descriptive study is the first to address
a long-standing research gap on psychiatric disorders in
adolescents and young adults with Down syndrome and
other intellectual disabilities. Although not applicable to
the population of those with ID or Down syndrome, the
young patients in this study had high rates of such se-
vere psychiatric conditions as psychosis, bipolar, mood,
and impulse control disorders. Findings offer important
insights into atypical aspects of the Down syndrome
phenotype, with group and gender differences that en-
courage new avenues of future research.
Unexpectedly, psychosis NOS was seen in 35% of the
49 patients with Down syndrome, significantly higher
than the 13% with psychosis in the ID group. An add-
itional 8% of patients with Down syndrome had depres-
sion with psychotic features. Although the rate of
psychosis in the ID group is consistent with previous
clinical studies [28,29], psychosis is not generally
reported in population-based or community samples of
people with Down syndrome [18]. Psychotic symptoms
have, however, been reported in hospitalized or clinic
adult patients with Down syndrome and in older adults
with dementia. For example, auditory hallucinations
were reported in 45% of 22 adult patients with Down
syndrome and depression [30], and Urv et al. [5] identi-
fied delusions or hallucinations in up to 79% of older
adults over the age of 50 with possible or definite
dementia. The present study, however, identified psychotic
symptoms in a much younger cohort.
Two cautionary notes are in order about psychotic
symptoms in people with Down syndrome or other IDs.
First, some cognitive processes in people with intellec-
tual impairments could easily be confused with delu-
sions or hallucinations, but are instead consistent with
mental age expectations and pre-operational levels of
cognitive development [31]. These processes include a
blurring of what is real versus pretend, having fantasies
or imaginary friends, and engaging in overly concrete or
magical thinking. Second, persons with Down syndrome
often talk or mumble to themselves. Glenn and Cun-
ningham [32] found that 91% of a sample of 77 young
adults with Down syndrome either talked to themselves
now or had done so in the past. Self-talk was often usedto guide problem solving or revisit previous conversa-
tions and activities, and it was not related to social or
behavioral problems. Both cognitive development and
benign self-talk thus need to be taken into account when
evaluating possible delusions or hallucinations in people
with Down syndrome or ID.
Unexpectedly, females comprised a full 81% of Down
syndrome patients with psychosis. Gender differences in
psychosis are not found in the general population [27],
nor were they seen in our ID group. As such, the pre-
ponderance of psychosis in young women with Down
syndrome may simply be a function of chance. On the
other hand, we examined the 22 cases of major depres-
sion in adults with Down syndrome reported by Meyers
and Pueschel [15] and discovered that females com-
prised 70% of those with hallucinations.
Women with Down syndrome may be more suscep-
tible to early aging, as well as premature menopause and
reduced levels of estrogen [33,34]. Schupf et al. [35]
found that women with Down syndrome and specific
polymorphisms in the estrogen receptor gene 1 were
three times more likely than women without these poly-
morphisms to develop Alzheimer’s disease. Although
speculative, alterations in estrogen receptors and
reduced estradiol availability may play a role in aberrant
cognitive or emotional functioning in younger women
with Down syndrome.
Relative to patients with ID, those with Down syn-
drome did not show higher rates of anxiety or depressive
disorders. A well-controlled study of adults with Down
syndrome who averaged 43 years of age also found rates
of depression that were similar to others with ID [18].
However, high rates of depression or depressive symp-
tomatology have previously been reported in older adults
with Down syndrome [12-15], including withdrawal,
irritability, mutism, and urinary incontinence [5,18].
These symptoms require careful evaluation as they may
also signal the beginning stages of dementia. Advancing
age may thus be a risk factor for depression in Down
syndrome, yet the course of depressive symptoms from
young to older adulthood is largely unknown.
Prominent slowing was observed in 17% of the Down
syndrome group, and only in those with psychosis, anx-
iety, or depression. It was common for these individuals
to take hours to complete otherwise routine grooming
or feeding activities, to passively refuse to engage in ac-
tivities they previously enjoyed, and to have pronounced
delays (up to 20 min) in responding to simple queries
that they had previously mastered (for example, ‘What is
your name?’, ‘What color are your socks?’). Charlot and
colleagues [23] attributed such ‘obsessional slowness’ in
their patients to an extreme form of obsessive-
compulsive disorder (OCD) and possible dopaminergic
dysfunction.
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our sample met criteria for OCD and instead bear a
striking resemblance to two case reports of Down syn-
drome and catatonia reported by Jeb and Ghaziuddin
[36]. These adolescent females had withdrawal, halluci-
nations, blunted affect, posturing, and psychomotor
slowing, and they responded well to conventional treat-
ment for catatonia. On an intriguing historical note, in
1946, Rollins [37] described ‘catatonic psychosis’ in 29%
of 73 institutionalized adolescents and young adults with
Down syndrome characterized by regression in speech,
toileting and feeding skills, docility, inertia, apathy and
withdrawal, motor rigidity, and unpredictable bouts of
excitation. Although the diagnosis of catatonia may be
underrecognized in contemporary psychiatric practice
[38], it is much more common in those with versus
without intellectual disabilities [39]. Future studies are
needed that probe neurological, motor and physiological
functioning in individuals with Down syndrome, and ap-
parent catatonia.
Consistent with previous studies, impulse control disor-
ders were more common in the ID versus Down syndrome
group; these were the most frequently occurring diagnosis
in our ID sample. Poor impulse control and aggressive be-
haviors in people with ID remain the leading reasons for
caregivers to seek specialized care [40,41]. As in previous
work, impulse control problems in our Down sample were
more common in males and in adolescents versus young
adults [15,19,20,30].
Relative to those with Down syndrome, the ID group
had significantly higher rates of bipolar disorder (4% ver-
sus 29%, respectively). Relatively high rates of bipolar
disorder have also been identified in other specialized
psychiatric clinics for persons with ID, ranging from
26.5% to 42% of 200 and 166 patients with ID, respect-
ively [41,42]. In contrast, studies conducted abroad find
much lower rates of bipolar in ID samples, from 1% to
3% [28,43,44], raising the possibility that ID studies in
the US mirror the increase in bipolar disorder diagnoses
among children or youth in the general population. De-
bates continue about the extent to which chronic irrit-
ability, impulsivity, and explosiveness are valid indices of
bipolar disorder in children or youth [45], or are instead
subsumed under a new DSM-5 diagnosis ‘disruptive
mood dysregulation disorder.’ Future research on bipolar
diagnoses in youth with ID stands to benefit from these
ongoing debates.
This study had several limitations. The sample size
was relatively small, primarily because of our restricted
age range and focus on patients in specialized psychiatric
clinics. Second, clinicians did not utilize standardized
psychiatric interviews. Even though clinicians were well
trained in ID and also used a team approach, they may
have overlooked concerns that are required probes instandardized interviews. Third, we were not able to obtain
systematic data on the types or dosages of prescribed med-
ications. Psychotropic medications have, however, been
studied in much larger samples of people with ID and
consistently show high levels of anticonvulsant and anti-
psychotic drug use relative to antidepressants or anxio-
lytics, as well as high rates of polypharmacy [29,46,47].
Future large-scale studies are needed that differentiate
psychotropic medication use in specific etiologies, includ-
ing Down syndrome.
The study did not formally measure relations between
psychiatric symptoms and specific life events. Anecdotally,
we noted that many young adults with Down syndrome
had graduated from high school but were then left with
little or nothing to do during the day. These informal ob-
servations warrant further study, as isolation and a lack of
stimulating cognitive, physical, or recreational activities
are risk factors for poorer outcomes in typical aging, as
well as in depression and dementia [48,49]. A final limita-
tion is that the clinics were not set up to conduct in-depth
medical evaluations. Even so, clinicians ruled out medical
conditions that are known to contribute to emotional or
behavioral problems in the ID population, such as
undetected or untreated pain, constipation, reflux, poor
sleep, low thyroid, and untreated infections [50,51].
Conclusions
Although clinic samples are not representative of broader
populations, this study nonetheless highlights an urgent
need for further research on psychiatric problems in youth
and young adults with ID and Down syndrome. Work is
especially needed on the high rates of apparent bipolar
disorder in youth with ID, including the extent to which
they respond to conventional bipolar treatment, have posi-
tive family histories of bipolar illness, or could instead be
diagnosed with other disorders, including the new DSM-5
disruptive mood dysregulation disorder.
Future research is also needed on the pronounced
withdrawal, psychosis, and apparent catatonia in some
patients with Down syndrome. This research needs to
identify the onset and course of such symptoms and
their associations to aberrant neurologic, hormonal and
neuroendocrine functioning, altered gene expression,
acute or chronic illnesses, stressful life events, and inad-
equate environmental stimulation. From 1946 to today,
different terms have been used to describe subsets of
individuals with Down syndrome and severe clinical pre-
sentations, including catatonic psychosis, young adult
disintegrative syndrome, depression, psychosis, catato-
nia, regression, and obsessional slowing. Although not
well understood, research on these severe psychiatric
presentations in youth and young adults stand to inform
treatment options and add new dimensions to our
phenotypic understandings of Down syndrome.
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